Actively Recruiting
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
Led by Arizona State University · Updated on 2025-07-17
144
Participants Needed
1
Research Sites
180 weeks
Total Duration
On this page
Sponsors
A
Arizona State University
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Engaging in regular physical activity during midlife is a key lifestyle behavior associated with reduced risk for Alzheimer's disease and related dementias (AD/ADRD). Yet nearly half of midlife adults (48%) do not meet national physical activity guidelines. The purpose of this mechanistic trial is to identify effective goal setting techniques to enhance psychosocial processes of self-regulation for the successful promotion of PA and adherence to national PA guidelines among midlife adults, with the long-term goal of reducing AD/ADRD risk
CONDITIONS
Official Title
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 45 to 65 years
- Body mass index (BMI) between 30 kg/m2 and 50 kg/m2
- Weigh at least 110 pounds
- Engaging in 60 minutes or less of self-reported moderate-to-vigorous physical activity at screening
- Own a smartphone with iOS or Android operating system
You will not qualify if you...
- Answering yes to any Physical Activity Readiness Questionnaire (PAR-Q) item without a physician's note
- Resting blood pressure greater than 200/110 mmHg without a physician's note
- Pregnant or planning to become pregnant in the next 8 months (Phase 1) or 12 months (Phase 2)
- Planning to move away from metropolitan Phoenix, Arizona in the next 8 months (Phase 1) or 12 months (Phase 2)
- Participating in another physical activity, nutrition, or weight loss program currently or during the intervention
- Diagnosed with mild cognitive impairment (MCI) or scoring below cutoffs on the Montreal Cognitive Assessment (MoCA)
- Previously prescribed any of the five approved Alzheimer's medications
- Scoring 16 or higher on the Center for Epidemiological Studies-Depression Scale (CES-D)
- Currently diagnosed with major depression
- Taking two or more antidepressant drugs
- History of stroke
- Being incarcerated (prisoner)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Arizona State University
Phoenix, Arizona, United States, 85004
Actively Recruiting
Research Team
R
Rodney Joseph, PhD
CONTACT
M
Molly Maxfield, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here